How many insider trades does FilingIQ track for NGNE?

FilingIQ tracks 39 Form 4 insider transactions for NGNE (Neurogene Inc.), covering filings from Mar 13, 2024 onwards. 25 of those were filed in the last 90 days.

Are NGNE insiders net buyers or net sellers?

Across the full Form 4 history for NGNE, 6 transactions (15%) were open-market purchases and 14 (36%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NGNE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NGNE in?

Neurogene Inc. (NGNE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $304.84M.

NGNE insider trading

NasdaqGM Healthcare

Neurogene Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

15% / 36%

Market cap

$304.84M

About Neurogene Inc.

Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.

Company website: www.neurogene.com

NGNE insider activity at a glance

FilingIQ has scored 39 insider transactions for NGNE since Mar 13, 2024. The most recent filing in our index is dated May 6, 2026.

Across the full history, 6 open-market purchases and 14 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NGNE insider trades is 55.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NGNE trades on FilingIQ Raw filings on SEC EDGAR

Latest NGNE Form 4 filings

Cvijic Christine Mikail President and CFO

P Nov 22, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding NGNE

Casdin Capital, LLC

$19.09M · 1.5% of AUM

Frequently asked

How many insider trades does FilingIQ track for NGNE?: FilingIQ tracks 39 Form 4 insider transactions for NGNE (Neurogene Inc.), covering filings from Mar 13, 2024 onwards. 25 of those were filed in the last 90 days.
Are NGNE insiders net buyers or net sellers?: Across the full Form 4 history for NGNE, 6 transactions (15%) were open-market purchases and 14 (36%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NGNE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NGNE in?: Neurogene Inc. (NGNE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $304.84M.

Methodology & sources

Every NGNE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.